|
⚲
|
| Keyboard |
| ABV LLC
✚
|
|
|---|---|
| CRD # | 163726 |
| SEC # | 802-76261 |
| CIK # | 0001599498 |
| AUM | |
| Employees | |
| Fees | |
| Minimum | |
| Phone | 212-688-8897 |
| Address | 1 Rockefellerplaza New York, NY 10020 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| VC | Ascent Biomedical Ventures I Annex LP | 2014-03-31 | 17.4 M | |
| VC | ABVS Fund Cayman Ltd | 2012-03-30 | ||
| Other | Ascent Biomedical Holdings LP | 2012-03-30 | 7.0 M | |
| VC | Ascent Biomedical Ventures II LP | 2012-03-30 | 36.7 M | |
| VC | Ascent Biomedical Ventures II NY LP | 2012-03-30 | 17.4 M | |
| VC | Ascent Biomedical Ventures I LP | 2012-03-30 | 25.3 M | |
| VC | Ascent Biomedical Ventures I NY LP | 2012-03-30 | 4.8 M | |
| VC | Ascent Biomedical Ventures Synecor LP | 2012-03-30 | 7.5 M |
| AUM Breakdown | Accounts | AUM ($) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 0 | 0.0 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 0 | 0.0 |
| By Discretionary | ||
| Discretionary | 0 | 0.0 |
| Non-Discretionary | 0 | 0.0 |
| Total | 0 | 0.0 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 0.0 | |
| Total | 0 | 0.0 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001599498] | |
| 4 | [0001599498] | |
| SC 13G | [0001599498] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| ABV LLC | Motus GI Holdings Inc | [2019-02-13] |
| ABV LLC | Cara Therapeutics Inc | [2014-02-10] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| ABV LLC | |
| Motus GI Holdings Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Motus GI Holdings Inc MOTS
Common Stock, par value $0.0001 per share
|
2018-05-31 | Other | 1,000,000 | ||
|
Motus GI Holdings Inc MOTS
Common Stock, par value $0.0001 per share
|
2018-02-16 | Conversion | 144,352 | $0.00 | |
|
Motus GI Holdings Inc MOTS
Series A Convertible Preferred Stock · derivative
|
2018-02-16 | Conversion | 144,352 | $0.00 | |
|
Motus GI Holdings Inc MOTS
Common Stock, par value $0.0001 per share
|
2018-02-16 | Conversion | 26,241 | $0.00 | |
|
Motus GI Holdings Inc MOTS
Warrant (right to buy) · derivative
|
2018-02-16 | Other | 159,149 | $0.00 | |
|
Motus GI Holdings Inc MOTS
Series A Convertible Preferred Stock · derivative
|
2018-02-16 | Conversion | 26,241 | $0.00 | |
|
Motus GI Holdings Inc MOTS
Warrant (right to buy) · derivative
|
2018-02-16 | Other | 61,125 | $0.00 |